KINSHASA, Democratic Republic of the Congo / RankWire.AI / – In Kisangani, the capital of Tshopo Province, health authorities in the Democratic Republic of the Congo have launched a targeted Ebola immunization campaign to stem the deadliest outbreak in the country’s history. Frontline healthcare workers, emergency response teams, and individuals with direct contact to confirmed cases are being prioritized during the initial deployment phase. Health Minister Roger Kamba confirmed that the government has begun using doses of the Ervebo vaccine to protect front-line personnel working in the affected eastern regions.
Official data from epidemiological sources shows that the outbreak has spread across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Statistics from the Ministry of Public Health and Prevention reveal that there have been 5,713 confirmed cases and 2,744 fatalities thus far. The current case fatality rate among confirmed cases is approximately 48%.
International health agencies have responded to the public health emergency, including the World Health Organization, to assist local medical teams with logistics, laboratory testing, and vaccine distribution efforts. The Ervebo vaccine is being administered under a compassionate-use protocol while researchers collect observational data regarding its effectiveness against the circulating viral strain. DR Congo begins Ebola vaccination efforts as health workers reinforce ring-vaccination strategies around identified clusters to break transmission chains.
Ebola Vaccination Efforts Initiated in Eastern Congo’s Affected Provinces
Operational challenges in logistics are present due to regional infrastructure complexities, ongoing security issues, and high mobility across border zones. Kisangani has established cold-chain supply systems to preserve vaccines at ultra-low temperatures before transportation to distant health districts. The Ebola vaccination initiative is underway, with civil defense and community health workers engaging in educational outreach to enhance disease surveillance and reporting mechanisms.
Epidemiologists from the Africa Centres for Disease Control and Prevention are working alongside local teams to monitor vaccine safety and assess immune responses among vaccinated populations. Early detection, combined with isolation measures and supportive treatment, remains crucial for improving patient survival rates. Additional vaccine shipments are planned as distribution efforts expand to secondary health districts across the region.
Kisangani as the Main Hub for Regional Ebola Vaccine Distribution
Contact-tracing operations are being intensified nationwide, especially across urban centers and rural communities in the eastern regions. Local health centers are supplied with personal protective equipment, diagnostic reagents, and therapeutic materials to bolster preparedness. Government officials confirmed that public health measures will remain active until viral transmission rates show consistent decline across all affected provinces.
The government urged local communities to fully cooperate with mobile vaccination teams and follow established sanitary protocols. It is expected that rising immunization coverage among high-risk groups will lead to stabilization of infection rates in the upcoming weeks. Surveillance systems will continue vigilant monitoring at transportation hubs and border crossings to prevent further geographic spread.